Document is current
Any future updates will be listed below
-
Authors
Altamura, Claudia https://orcid.org/0000-0002-5934-5535
Ornello, R. https://orcid.org/0000-0001-9501-4031
Ahmed, F. https://orcid.org/0000-0002-2746-0889
Negro, A. https://orcid.org/0000-0003-3590-298X
Miscio, A. M.
Santoro, A.
Alpuente, A. https://orcid.org/0000-0001-5296-9401
Russo, A.
Silvestro, M.
Cevoli, S. https://orcid.org/0000-0003-4668-4295
Brunelli, N. https://orcid.org/0000-0002-8590-9015
Grazzi, L. https://orcid.org/0000-0001-6535-1109
Baraldi, C. https://orcid.org/0000-0001-8432-1888
Guerzoni, S. https://orcid.org/0000-0001-9589-2782
Andreou, A. P. https://orcid.org/0000-0002-7008-6626
Lambru, G. https://orcid.org/0000-0002-2780-4776
Frattale, I.
Kamm, K.
Ruscheweyh, R. https://orcid.org/0000-0001-9510-7158
Russo, M. https://orcid.org/0000-0001-5171-8555
Torelli, P. https://orcid.org/0000-0002-4072-2353
Filatova, E.
Latysheva, N. https://orcid.org/0000-0001-9600-5540
Gryglas-Dworak, A.
Straburzynski, M. https://orcid.org/0000-0002-9811-3526
Butera, C.
Colombo, B.
Filippi, M. https://orcid.org/0000-0002-5485-0479
Pozo-Rosich, P. https://orcid.org/0000-0003-0796-4702
Martelletti, P. https://orcid.org/0000-0002-6556-4128
Sacco, S. https://orcid.org/0000-0003-0651-1939
Vernieri, F. https://orcid.org/0000-0002-9594-9336
- License Information
-
More Information
Article History
Received: 19 July 2022
Revised: 17 October 2022
Accepted: 25 October 2022
First Online: 3 November 2022
Declarations
:
: Claudia Altamura received travel grants and honoraria from Novartis, Eli Lilly, Allergan, Lusofarmaco and Laborest, she serves as Associate Editor for Frontiers in Human Neuroscience. Raffaele Ornello reports speaker fees from Novartis and Eli Lilly, travel grants from Teva, and support for publication from Novartis and Allergan. Simona Sacco reports personal fees from Allergan-AbbVie, AstraZeneca, Abbott, Teva, Novartis, Novo Nordisk, Medscape, Neurodiem, and Eli Lilly. Alicia Alpuente has received honoraria for educational projects from Allergan-Abbvie, Novartis and Teva. Patricia Pozo-Rosich has received honoraria as a consultant and speaker for Allergan-Abbvie, Almirall, Amgen, Biohaven, Chiesi, EliLilly, Medscape, Neurodiem, Novartis and Teva; her research group has received research grants from Allergan, and has received funding for clinical trials from Alder, Allergan-Abbvie, Electrocore, Eli Lilly, Novartis and Teva; she is a trustee member of the board of the International Headache Society, member of the Council of the European Headache Society; she is in the editorial board of Revista de Neurologia, associate editor for Cephalalgia, Headache, Neurologia, Frontiers of Neurology and advisor for The Journal of Headache and Pain; she is a member of the Clinical Trials Guidelines Committee of the International Headache Society; she has edited the Guidelines for the Diagnosis and Treatment of Headache of the Spanish Neurological Society; she is the founder of ; she does not own stocks from any pharmaceutical company. Andrea Negro has received speaking honoraria and has served on the advisory boards of Allergan, EliLilly and Company and Novartis. Paolo Martelletti has received speaker’s honoraria and has served on the advisory boards of Allergan, Eli Lilly and Company, Novartis and Teva Pharmaceuticals; he is also an EMA Expert and has served as Editor in Chief for The Journal of Headache and Pain and as Editor in Chief for Springer Nature Comprehensive Clinical Medicine; he also declares received royalties from SpringerNature. Massimo Filippi is Editor-in-Chief of the Journal of Neurology and Associate Editor of Neurological Sciences, received compensation for consulting services and/or speaking activities from Bayer, Biogen Idec, Merck-Serono, Novartis, Roche, Sanofi Genzyme, Takeda, and Teva Pharmaceutical Industries; and receives research support from Biogen Idec, Merck-Serono, Novartis, Teva Pharmaceutical Industries, Roche, Italian Ministry of Health, Fondazione Italiana Sclerosi Multipla, and ARiSLA (Fondazione Italiana di Ricerca per la SLA). Elena Filatova reports speaker fees from Novartis and Teva. Nina Latysheva reports speaker fees from Novartis and Allergan. Carlo Baraldi received travel grants and honorary from Allergan, Novartis, Teva and Ely Lilly. Licia Grazzi has received consultancy and advisory fees from Allergan, Electrocore LLC, Novartis, and EliLilly, and collaborates in trials sponsored by EliLilly, Teva, and PharmInd. Simona Guerzoni received travel grants and honorary from Allergan, Eli Lilly, TEVA and Novartis. Sabina Cevoli received honoraria as speaker, for participating in advisory boards or for clinical investigation studies from Teva, Allergan, Novartis, Lilly, Ibsa. Fayyaz Ahmed has received honorarium from Allergan for being on their advisory board and is paid to the charitable organisations. Giorgio Lambru has received speaker honoraria, funding for travel and has received honoraria for participation in advisory boards sponsored by Allergan, Novartis, Eli Lilly and TEVA; he has also received speaker honoraria, funding for travel from electroCore, Nevro Corp. and Autonomic Technologies. Anna P. Andreou received speaker honoraria and funding for travel from Allergan, Eli Lilly and eNeura honoraria for participation in advisory boards sponsored by Allergan and Eli Lilly, sponsorship for educational purposes from eNeura, Allergan, Autonomic Technologies and Novartis, and an equipment grant from eNeura. Antonio Russo has received speaker honoraria from Allergan, Lilly, Novartis and Teva and serves as an associate editor of Frontiers in Neurology(Headache Medicine and Facial Pain session). Marcello Silvestro has received speaker honoraria from Lilly, Novartis and Teva. Ruth Ruscheweyh has received travel grants and/or honoraria from Allergan, Hormosan, Lilly Novartis and Teva. Fabrizio Vernieri received travel grants, honoraria for advisory boards and speaker panels from Allergan, Angelini, Lilly, Novartis, and Teva. Marcin Straburzynski received personal fees from Novartis and Teva. Katharina Kamm received travel grants and/or honoraria from Lilly, Novartis and Teva. Paola Torelli has received travel grants and/or honoraria from Allergan, Lilly, Novartis and Teva. Anna Gryglas-Dwora has received honoraria as a speaker and travel grants from Allergan and honoraria as a speaker from Novartis. Colombo received grant for advisory board and travel from Teva, Novartis, Merck-Serono, Lilly, Biogen Anna Maria Miscio, Antonio Santoro Nicoletta Brunelli, Calogera Butera and Marco Russo have nothing to disclose.
: The study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments. Informed consent was obtained from patients for collecting anonymously clinical and demographics data.
